1. Home
  2. PYPD
  3. PYPD News

Latest PolyPid Ltd. (PYPD) News on June 6, 2025

Salesforce initiated, Dollar Tree upgraded: Wall Street’s top analyst calls
PYPD

TipRanks

5 hours ago

Salesforce initiated, Dollar Tree upgraded: Wall Street’s top analyst calls

PYPD: Assessing & Advancing Lead Candidate D-PLEX₁₀₀, Through Clinical Trials to Improve Surgical Outcomes, Enhance Treatment Efficacy, Minimize Side Effects
PYPD

Zacks Small Cap Research

4 days ago

PYPD: Assessing & Advancing Lead Candidate D-PLEX₁₀₀, Through Clinical Trials to Improve Surgical Outcomes, Enhance Treatment Efficacy, Minimize Side Effects

PolyPid to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025
PYPD

GlobeNewswire

17 days ago

PolyPid to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025

PYPD

GuruFocus.com

22 days ago

PolyPid Ltd (PYPD) Q1 2025 Earnings Call Highlights: Strategic Advances Amid Financial Challenges

PolyPid Provides Corporate Update and Reports First Quarter 2025 Financial Results
PYPD

GlobeNewswire

23 days ago

PolyPid Provides Corporate Update and Reports First Quarter 2025 Financial Results

PolyPid to Report First Quarter 2025 Financial Results and Operational Highlights on May 14, 2025
PYPD

GlobeNewswire

a month ago

PolyPid to Report First Quarter 2025 Financial Results and Operational Highlights on May 14, 2025

PolyPid to Participate in The Citizens Life Sciences Conference
PYPD

GlobeNewswire

a month ago

PolyPid to Participate in The Citizens Life Sciences Conference

Q1 Virtual Investor Summit: On-Demand Presentations Now Live
PYPD

ACCESS Newswire

3 months ago

Q1 Virtual Investor Summit: On-Demand Presentations Now Live

PolyPid Announces Successful Completion of Enrollment in Phase 3 SHIELD II Trial of D-PLEX₁₀₀ for the Prevention of Abdominal Colorectal Surgical Site Infections
PYPD

GlobeNewswire

3 months ago

PolyPid Announces Successful Completion of Enrollment in Phase 3 SHIELD II Trial of D-PLEX₁₀₀ for the Prevention of Abdominal Colorectal Surgical Site Infections

PolyPid to Participate in the 37th Annual ROTH Conference
PYPD

GlobeNewswire

3 months ago

PolyPid to Participate in the 37th Annual ROTH Conference

PYPD

GuruFocus.com

4 months ago

PolyPid Ltd (PYPD) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Rising R&D Costs

PolyPid Provides Corporate Update and Reports Fourth Quarter and Full-Year 2024 Financial Results
PYPD

GlobeNewswire

4 months ago

PolyPid Provides Corporate Update and Reports Fourth Quarter and Full-Year 2024 Financial Results

PolyPid to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
PYPD

GlobeNewswire

4 months ago

PolyPid to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

PolyPid to Report Fourth Quarter and Full-Year 2024 Financial Results and Operational Highlights on February 12, 2025
PYPD

GlobeNewswire

4 months ago

PolyPid to Report Fourth Quarter and Full-Year 2024 Financial Results and Operational Highlights on February 12, 2025

PYPD

MT Newswires

5 months ago

PolyPid Eyes Results From D-PLEX100 Trial in Q2 After Independent Board Gives Nod to Complete Enrollment

PolyPid Announces Positive Recommendation by DSMB to Continue Enrollment of Phase 3 SHIELD II Trial of D-PLEX₁₀₀ to 800 Patients with a Concurrent Private Placement of up to $41 Million
PYPD

GlobeNewswire

5 months ago

PolyPid Announces Positive Recommendation by DSMB to Continue Enrollment of Phase 3 SHIELD II Trial of D-PLEX₁₀₀ to 800 Patients with a Concurrent Private Placement of up to $41 Million

PolyPid announces research, development collaboration with ImmunoGenesis
PYPD

TipRanks

6 months ago

PolyPid announces research, development collaboration with ImmunoGenesis

PolyPid Announces Research and Development Collaboration with ImmunoGenesis Leveraging PLEX Technology to Enhance Cancer Immunotherapy
PYPD

GlobeNewswire

6 months ago

PolyPid Announces Research and Development Collaboration with ImmunoGenesis Leveraging PLEX Technology to Enhance Cancer Immunotherapy

PolyPid Announces Receipt of Nasdaq Notification of Minimum Stockholders’ Equity Non-Compliance
PYPD

GlobeNewswire

6 months ago

PolyPid Announces Receipt of Nasdaq Notification of Minimum Stockholders’ Equity Non-Compliance

PYPD

GuruFocus.com

7 months ago

PolyPid Ltd (PYPD) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges

PolyPid Provides Corporate Update and Reports Third Quarter 2024 Financial Results
PYPD

GlobeNewswire

7 months ago

PolyPid Provides Corporate Update and Reports Third Quarter 2024 Financial Results

PolyPid to Participate in the Craig-Hallum 15th Annual Alpha Select Conference
PYPD

GlobeNewswire

7 months ago

PolyPid to Participate in the Craig-Hallum 15th Annual Alpha Select Conference

PolyPid to Report Third Quarter 2024 Financial Results and Operational Highlights on November 13, 2024
PYPD

GlobeNewswire

7 months ago

PolyPid to Report Third Quarter 2024 Financial Results and Operational Highlights on November 13, 2024

Rosalind Advisors, Inc. Reduces Stake in PolyPid Ltd
PYPD

GuruFocus.com

7 months ago

Rosalind Advisors, Inc. Reduces Stake in PolyPid Ltd

PolyPid Announces Publication in International Journal of Surgery Highlighting Results of Phase 3 SHIELD I Trial of D-PLEX₁₀₀ in Prevention of Surgical Site Infections in Abdominal Colorectal Surgery
PYPD

GlobeNewswire

8 months ago

PolyPid Announces Publication in International Journal of Surgery Highlighting Results of Phase 3 SHIELD I Trial of D-PLEX₁₀₀ in Prevention of Surgical Site Infections in Abdominal Colorectal Surgery

PolyPid Announces Last Patient In for Planned Unblinded Interim Analysis in the Ongoing SHIELD II Phase 3 Trial Evaluating D-PLEX₁₀₀ for the Prevention of Abdominal Colorectal Surgical Site Infections
PYPD

GlobeNewswire

8 months ago

PolyPid Announces Last Patient In for Planned Unblinded Interim Analysis in the Ongoing SHIELD II Phase 3 Trial Evaluating D-PLEX₁₀₀ for the Prevention of Abdominal Colorectal Surgical Site Infections

PolyPid to Participate in Three Upcoming Fall Investor Conferences
PYPD

GlobeNewswire

9 months ago

PolyPid to Participate in Three Upcoming Fall Investor Conferences

PYPD

MT Newswires

9 months ago

PolyPid Files for Potential Sale of 3.9 Million Shares

PolyPid Provides Corporate Update and Reports Second Quarter 2024 Financial Results
PYPD

GlobeNewswire

10 months ago

PolyPid Provides Corporate Update and Reports Second Quarter 2024 Financial Results

PolyPid Announces Private Placement for Up to $14 Million in Gross Proceeds
PYPD

GlobeNewswire

10 months ago

PolyPid Announces Private Placement for Up to $14 Million in Gross Proceeds

PolyPid to Report Second Quarter 2024 Financial Results and Operational Highlights on August 14, 2024
PYPD

GlobeNewswire

10 months ago

PolyPid to Report Second Quarter 2024 Financial Results and Operational Highlights on August 14, 2024

PYPD

MT Newswires

a year ago

PolyPid Registers $200 Million Ordinary Stock

PolyPid Hosts KOL Call to Discuss Significant Unmet Medical Need in Surgical Site Infections Prevention and Provides Update on its Ongoing SHIELD II Phase 3 Trial
PYPD

GlobeNewswire

a year ago

PolyPid Hosts KOL Call to Discuss Significant Unmet Medical Need in Surgical Site Infections Prevention and Provides Update on its Ongoing SHIELD II Phase 3 Trial

PolyPid to Host Virtual KOL Event on June 17, 2024, and Provide an Update on the Company’s Ongoing D-PLEX₁₀₀ Phase 3 Trial
PYPD

GlobeNewswire

a year ago

PolyPid to Host Virtual KOL Event on June 17, 2024, and Provide an Update on the Company’s Ongoing D-PLEX₁₀₀ Phase 3 Trial

PolyPid Ltd. (NASDAQ:PYPD) Q1 2024 Earnings Call Transcript
PYPD

Insider Monkey

a year ago

PolyPid Ltd. (NASDAQ:PYPD) Q1 2024 Earnings Call Transcript

PolyPid Provides Corporate Update and Reports First Quarter 2024 Financial Results
PYPD

GlobeNewswire

a year ago

PolyPid Provides Corporate Update and Reports First Quarter 2024 Financial Results

PolyPid to Participate in Citizens JMP Life Sciences Conference
PYPD

GlobeNewswire

a year ago

PolyPid to Participate in Citizens JMP Life Sciences Conference

PolyPid Announces Enrollment of 200th Patient in Ongoing SHIELD II Phase 3 Trial Evaluating D-PLEX₁₀₀ for the Prevention of Abdominal Colorectal Surgical Site Infections
PYPD

GlobeNewswire

a year ago

PolyPid Announces Enrollment of 200th Patient in Ongoing SHIELD II Phase 3 Trial Evaluating D-PLEX₁₀₀ for the Prevention of Abdominal Colorectal Surgical Site Infections

PolyPid to Report First Quarter 2024 Financial Results and Operational Highlights on May 8, 2024
PYPD

GlobeNewswire

a year ago

PolyPid to Report First Quarter 2024 Financial Results and Operational Highlights on May 8, 2024

PYPD: Polypid is Enhancing Surgical Outcomes
PYPD

Zacks Small Cap Research

a year ago

PYPD: Polypid is Enhancing Surgical Outcomes

PolyPid to Participate in Barclays 26th Annual Global Healthcare Conference
PYPD

GlobeNewswire

a year ago

PolyPid to Participate in Barclays 26th Annual Global Healthcare Conference

PolyPid Ltd. (PYPD) Upgraded to Buy: What Does It Mean for the Stock?
PYPD

Zacks

a year ago

PolyPid Ltd. (PYPD) Upgraded to Buy: What Does It Mean for the Stock?

PolyPid Ltd. (NASDAQ:PYPD) Q4 2023 Earnings Call Transcript
PYPD

Insider Monkey

a year ago

PolyPid Ltd. (NASDAQ:PYPD) Q4 2023 Earnings Call Transcript

PolyPid Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
PYPD

GlobeNewswire

a year ago

PolyPid Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results

PolyPid Announces Enrollment of the 100th Patient in the Ongoing SHIELD II Phase 3 Trial
PYPD

GlobeNewswire

a year ago

PolyPid Announces Enrollment of the 100th Patient in the Ongoing SHIELD II Phase 3 Trial

PolyPid to Report Fourth Quarter and Full-Year 2023 Financial Results and Operational Highlights on February 14, 2024
PYPD

GlobeNewswire

a year ago

PolyPid to Report Fourth Quarter and Full-Year 2023 Financial Results and Operational Highlights on February 14, 2024

We're Hopeful That InspireMD (NASDAQ:NSPR) Will Use Its Cash Wisely
PYPD

Simply Wall St.

a year ago

We're Hopeful That InspireMD (NASDAQ:NSPR) Will Use Its Cash Wisely

Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at University of Utah, an Internationally Recognized Center in Obstetrics and Gynecology
PYPD

GlobeNewswire

a year ago

Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at University of Utah, an Internationally Recognized Center in Obstetrics and Gynecology

Shareholders in Dawson Geophysical (NASDAQ:DWSN) are in the red if they invested five years ago
PYPD

Simply Wall St.

a year ago

Shareholders in Dawson Geophysical (NASDAQ:DWSN) are in the red if they invested five years ago

Notice of Deficiency with Nasdaq Continued Listing Requirements
PYPD

ACCESSWIRE

a year ago

Notice of Deficiency with Nasdaq Continued Listing Requirements

Genius Group Announces Pricing of $8.25 Million Public Offering
PYPD

GlobeNewswire

a year ago

Genius Group Announces Pricing of $8.25 Million Public Offering

Checkpoint Therapeutics to Participate in the B. Riley Securities 4th Annual Oncology Conference
PYPD

GlobeNewswire

a year ago

Checkpoint Therapeutics to Participate in the B. Riley Securities 4th Annual Oncology Conference

Inuvo's IntentKey AI Powers the Privacy-First, Post-Cookie Era
PYPD

GlobeNewswire

a year ago

Inuvo's IntentKey AI Powers the Privacy-First, Post-Cookie Era

GlocalMe Unveils Next-Level Global Connectivity Solutions at CES 2024
PYPD

PR Newswire

a year ago

GlocalMe Unveils Next-Level Global Connectivity Solutions at CES 2024

PolyPid Announces Private Placement for $16 Million in Gross Proceeds
PYPD

GlobeNewswire

a year ago

PolyPid Announces Private Placement for $16 Million in Gross Proceeds

European Patent Office Approves Key Patent for Indaptus Therapeutics’ Platform Technology
PYPD

GlobeNewswire

a year ago

European Patent Office Approves Key Patent for Indaptus Therapeutics’ Platform Technology

Assembly Biosciences Provides Anticipated Development Milestones for 2024
PYPD

GlobeNewswire

a year ago

Assembly Biosciences Provides Anticipated Development Milestones for 2024

Protalix BioTherapeutics Issues 2024 Letter to Stockholders
PYPD

PR Newswire

a year ago

Protalix BioTherapeutics Issues 2024 Letter to Stockholders

The 3 Most Undervalued AI Penny Stocks to Buy in December
PYPD

InvestorPlace

a year ago

The 3 Most Undervalued AI Penny Stocks to Buy in December

Red Cat Holdings, Inc. Announces Closing of $9.2 Million Public Offering
PYPD

GlobeNewswire

a year ago

Red Cat Holdings, Inc. Announces Closing of $9.2 Million Public Offering

Sphere 3D Corp. Provides November 2023 Production and Operation Updates
PYPD

Newsfile

2 years ago

Sphere 3D Corp. Provides November 2023 Production and Operation Updates

VBI Vaccines Presents Additional Biomarker Data from Phase 1/2a Study of VBI-1901 in Recurrent GBM at the 2023 Society for Neuro-Oncology (SNO) Annual Meeting
PYPD

Business Wire

2 years ago

VBI Vaccines Presents Additional Biomarker Data from Phase 1/2a Study of VBI-1901 in Recurrent GBM at the 2023 Society for Neuro-Oncology (SNO) Annual Meeting

Phoenix New Media Limited (NYSE:FENG) Q3 2023 Earnings Call Transcript
PYPD

Insider Monkey

2 years ago

Phoenix New Media Limited (NYSE:FENG) Q3 2023 Earnings Call Transcript

PYPD

Zacks Small Cap Research

2 years ago

CTSO: CytoSorbents reports 3rd quarter 2023 financial and operating results which showed strong product revenue growth and an improved cost structure.

PolyPid Ltd. (NASDAQ:PYPD) Q3 2023 Earnings Call Transcript
PYPD

Insider Monkey

2 years ago

PolyPid Ltd. (NASDAQ:PYPD) Q3 2023 Earnings Call Transcript

Great Elm Group, Inc. (NASDAQ:GEG) Q1 2024 Earnings Call Transcript
PYPD

Insider Monkey

2 years ago

Great Elm Group, Inc. (NASDAQ:GEG) Q1 2024 Earnings Call Transcript

PYPD

Thomson Reuters StreetEvents

2 years ago

Q3 2023 Real Good Food Company Inc Earnings Call

PYPD

Thomson Reuters StreetEvents

2 years ago

Q3 2023 Co-Diagnostics Inc Earnings Call

PYPD

Thomson Reuters StreetEvents

2 years ago

Q3 2023 Cytosorbents Corp Earnings Call

PYPD

Thomson Reuters StreetEvents

2 years ago

Q3 2023 Brilliant Earth Group Inc Earnings Call

The Real Good Food Company Reports Third Quarter 2023 Financial Results
PYPD

GlobeNewswire

2 years ago

The Real Good Food Company Reports Third Quarter 2023 Financial Results

Co-Diagnostics, Inc. Reports Third Quarter 2023 Financial Results
PYPD

PR Newswire

2 years ago

Co-Diagnostics, Inc. Reports Third Quarter 2023 Financial Results

PolyPid Provides Corporate Update and Reports Third Quarter 2023 Financial Results
PYPD

GlobeNewswire

2 years ago

PolyPid Provides Corporate Update and Reports Third Quarter 2023 Financial Results

Tritium Implements Strategic Plan to Achieve 2024 Profitability
PYPD

GlobeNewswire

2 years ago

Tritium Implements Strategic Plan to Achieve 2024 Profitability

PolyPid Announces the Addition of Dr. Nurit Tweezer-Zaks to its Board of Directors
PYPD

GlobeNewswire

2 years ago

PolyPid Announces the Addition of Dr. Nurit Tweezer-Zaks to its Board of Directors

Stonegate Capital Partners Updates Coverage on Independence Contract Drilling, Inc (ICD) Q3 2023
PYPD

Newsfile

2 years ago

Stonegate Capital Partners Updates Coverage on Independence Contract Drilling, Inc (ICD) Q3 2023

Allied Gaming & Entertainment Announces Closing of Strategic Investment to Become Largest Shareholder of Beijing Lianzhong Zhihe Technology Co.
PYPD

Business Wire

2 years ago

Allied Gaming & Entertainment Announces Closing of Strategic Investment to Become Largest Shareholder of Beijing Lianzhong Zhihe Technology Co.

Share on Social Networks: